KirenJeanKresa-ReahlMD

PubMed

• Treatment Patterns and Unmet Need for Patients with Progressive Multiple Sclerosis in the United States: Survey Results from 2016 to 2021.
  Crystal Watson, Dhanalakshmi Thirumalai, Arie Barlev, Eddie Jones, Sasha Bogdanovich, Kiren Kresa-Reahl> ;Neurology and Therapy. 2023 Dec 1
• 2 citations
  Results from Patient Interviews on Fatigue in Progressive Multiple Sclerosis and Evaluation of Fatigue Patient-Reported Outcome (PRO) Instruments.
  Crystal Watson, Kayla Scippa, Arie Barlev, Kiren Kresa-Reahl, Jason C Cole> ;Neurology and Therapy. 2022 Jun 1
• 4 citations
  Effectiveness of Dimethyl Fumarate in Patients With Relapsing Multiple Sclerosis Switching After Suboptimal Response to Glatiramer Acetate, Including Patients With Ear...
  Pavle Repovic, Derrick Robertson, Kiren Kresa-Reahl, Stanley Cohan, Ray Su, Robin Avila, Irene Koulinska, Jason P. Mendoza> ;Neurology and Therapy. 2021 Jun 1
• Corrigendum to "Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching Fr...
  Kiren Kresa-Reahl, Pavle Repovic, Derrick Robertson, Macaulay Okwuokenye, Leslie Meltzer, Jason P. Mendoza> ;Clinical Therapeutics. 2019 Jun 27
• 13 citations
  Comparative effectiveness of teriflunomide and dimethyl fumarate in patients with relapsing forms of MS in the retrospective real-world Teri-RADAR study.
  Robert Zivadinov, Kiren Kresa-Reahl, Bianca Weinstock-Guttman, Keith R. Edwards, Chakkarin Burudpakdee, Niels Bergsland, Michael G. Dwyer, Bhupendra O. Khatri, Karthin...> ;Journal of Comparative Effectiveness Research. 2019 Feb 13
• 4 citations
  Reducing return of disease activity in patients with relapsing multiple sclerosis transitioned from natalizumab to teriflunomide: 12-month interim results of terifluno...
  Stanley Cohan, Keith R. Edwards, Lindsay Lucas, Tiffany Gervasi-Follmar, Judy O'Connor, Jessica Siuta, Vineetha Kamath, Lore Garten, Chiayi Chen, James Thomas, Kyle Sm...> ;Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2019 Jan 16
• 26 citations
  Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Ac...
  Kiren Kresa-Reahl, Pavle Repovic, Derrick Robertson, Macaulay Okwuokenye, Leslie Meltzer, Jason P. Mendoza> ;Clinical Therapeutics. 2018 Nov 22
• 3 citations
  Outcomes of Stable Multiple Sclerosis Patients Staying on Initial Interferon Beta Therapy Versus Switching to Another Interferon Beta Therapy: A US Claims Database Study.
  Stanley Cohan, Kyle Smoot, Kiren Kresa-Reahl, Robert Garland, Wei-Shi Yeh, Ning Wu, Crystal Watson> ;Advances in Therapy. 2018 Oct 20
• 4 citations
  Addressing the targeting range of the ABILHAND-56 in relapsing–remitting multiple sclerosis: A mixed methods psychometric study:
  Sophie Cleanthous, Sara Strzok, Farrah Pompilus, Stefan J. Cano, Patrick Marquis, Stanley Cohan, Myla D. Goldman, Kiren Kresa-Reahl, Jennifer Petrillo, Carmen Castrill...> ;Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2018 May 17
• 6 citations
  Development of a gait module to complement the 12-item Multiple Sclerosis Walking Scale: a mixed methods study.
  Sara Strzok, Sophie Cleanthous, Farrah Pompilus, Stefan J. Cano, Patrick Marquis, Stanley Cohan, Myla D. Goldman, Kiren Kresa-Reahl, Jennifer Petrillo, Carmen Castrill...> ;Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2018 Apr 1
• 19 citations
  Three-year clinical outcomes of relapsing multiple sclerosis patients treated with dimethyl fumarate in a United States community health center.
  Kyle Smoot, Kateri J. Spinelli, Tamela Stuchiner, Lindsay Lucas, Chiayi Chen, Lois Grote, Elizabeth Baraban, Kiren Kresa-Reahl, Stanley Cohan> ;Multiple Sclerosis. 2018 Jun 1
• Join now to see all